Target intelligence / Profile preview

Forkhead box protein O (DAF-16) (DAF-16)

Target
DAF-16
Molecular classification
Transcription factor, Forkhead family, Forkhead box O (FOXO) subfamily
01

Overview

Forkhead box protein O (DAF-16), most commonly referred to as DAF-16, is the single homolog of the Forkhead box O (FOXO) family of transcription factors in *Caenorhabditis elegans*[5][4][3][8]. DAF-16 functions as a central regulator of the insulin/insulin-like growth factor signaling (IIS) pathway and integrates multiple upstream signals to control the expression of genes involved in longevity, stress resistance, metabolism, immunity, development, and apoptosis[5][4][1][3][9]. It activates genes that mediate adaptation to adverse environmental conditions, notably promoting longevity, dauer formation (a stress-resistant larval stage), and metabolic flexibility[5][4][3][6]. DAF-16 activity is modulated primarily by IIS but can also be regulated independently by kinases such as JNK-1 and CST-1 in response to specific stresses[10]. Locally, DAF-16 is activated by nuclear translocation upon IIS reduction, leading to broad changes in gene expression[2][9]. DAF-16 homologs in higher organisms (FOXO1, FOXO3, FOXO4, FOXO6) are closely related and function similarly in aging and metabolic regulation[1]. The DAF-16 target pathway has been a cornerstone of research into molecular mechanisms of aging and stress resistance in multicellular organisms[5][4][3]. Currently, there are no direct drugs targeting DAF-16 as a therapeutic target, and it is predominantly studied as a genetic model for understanding conserved biology.

Other names
FOXO homologForkhead box OFOXO (in C. elegans)daf-16 (gene)DAF-16/FoxOForkhead transcription factor class O
02

Biological functions

Regulation of lifespan/longevityStress resistance (oxidative, heat shock)Metabolism (lipogenesis, fat and carbohydrate metabolism)Regulation of development (dauer formation)Regulation of gene expression in response to the insulin/IGF-1 signaling (IIS) pathwayImmunity/infection responseCell cycle arrestApoptosis
03

Disease associations

Aging/longevityMetabolic disease (in model organisms)Stress-related disorders (model)Cancer (implications from conserved functions in mammals)Diabetes (implications from conserved functions in mammals)

Beyond the preview

Go deeper on Forkhead box protein O (DAF-16) (DAF-16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Forkhead box protein O (DAF-16) (DAF-16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call